Leukemia, Myelodysplasia, Transplantation
Community Translations
Obinutuzumab for previously untreated chronic lymphocytic leukemia
Obinutuzumab was approved by the Food and Drug Administration in late 2013 for use in combination with chlorambucil for the treatment of patients...
Conference Coverage
Team identifies potential treatment for FLT3-ITD AML
Credit: Eric Smith Researchers have presented evidence to support the use of a BET protein antagonist in FLT3-ITD-mutated acute myeloid leukemia...
News
FDA lifts clinical hold on CAR T-cell study
Credit: MSKCC The US Food and Drug Administration (FDA) has lifted a clinical hold placed on a trial of chimeric antigen receptor (CAR) T-cell...
News
Drug gets orphan designation for AML
Credit: NIH The US Food and Drug Administration and the European Commission have granted volasertib orphan designation for the treatment of acute...
News
Explaining the link between Down syndrome and B-ALL
Credit: Aaron Logan Investigators believe they’ve uncovered information that explains the connection between Down syndrome and B-cell acute...
Conference Coverage
Molecule shows preclinical activity in leukemias, lymphomas
SAN DIEGO—A small molecule that has previously proven effective against solid tumors exhibits activity against leukemias and lymphomas,...
News
FDA approves ofatumumab in combination for CLL
Credit: Linda Bartlett The US Food and Drug Administration (FDA) has approved ofatumumab (Arzerra) in combination with chlorambucil for...
News
Novel epigenetic treatment showed activity in hematologic cancers
Major Finding: Among 38 patients with a variety of hematologic cancers who were treated with the novel bromodomain and extraterminal bromodomain...
News
Protective cells are impaired in aggressive CLL
Credit: Monash University New research may explain why patients with chronic lymphocytic leukemia (CLL) are vulnerable to severe, recurrent...
News
Patient perception of control affects satisfaction
patient and her father Credit: Rhoda Baer Feeling as though they play an active role in their treatment decisions increases satisfaction among...
Conference Coverage
Group describes mechanism of resistance in CLL
The study suggests the TNF-family member BAFF contributes to CLL cells’ resistance to direct and rituximab-induced natural killer (NK) cell...